MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Galmed Pharmaceuticals Ltd Company Profile (NASDAQ:GLMD)

Consensus Ratings for Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $21.50 (448.47% upside)

Analysts' Ratings History for Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)
Show:
DateFirmActionRatingPrice TargetActions
5/16/2016Maxim GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016FBR & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2015MLV & Co.Reiterated RatingBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2015SunTrustLower Price TargetBuy$20.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2015Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/31/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha